In concordantly, GBM cell lines were more sensitive to the CDK2 inhibitors with lower IC50 values (median IC50: 19.09 μM in GBMs vs 53.96 μM in LGGs) (Fig. 2J). This evidence concerns the gene CDK2 and glioblastoma.